Trial Profile
Phase III study of ORADUR hydromorphone in the treatment of pain
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Cassava Sciences
- 29 May 2015 New trial record
- 07 Aug 2014 Pain Therapeutics expects to initiate this study in 2015, according to a DURECT Corporation media release.